This program focuses on the legal framework and regulatory requirements governing the advertising and promotion of prescription drugs under the Food, Drug, and Cosmetic Act (FDCA).
This presentation examines the evolving regulatory landscape of clinical research compliance, emphasizing how multiple federal and state agencies—beyond the FDA—are shaping enforcement priorities in the clinical trial space.
This course will explore product liability lawsuits filed against cosmetic companies for failure to warn consumers about a link to reproductive health problems.